Ticker
$CVKD
1 catalyst touching CVKD in the last 60 days, newest first, each with the price move that followed.
- 65
Cadrenal initiates formal strategic review for asset sales or M&A
Cadrenal's Board has authorized a formal strategic process to evaluate licensing, asset sales, partnerships, or business combinations to maximize shareholder value. The review is preliminary with no deadline, but signals the company is actively exploring value-accretive transactions that could include M&A.
CVKD ▲SEC 8-K · 7 Oct 2026, 13:23 UTC
Information only. AURA does not give buy or sell recommendations.